Search

Your search keyword '"Takeuchi, Ken"' showing total 1,054 results

Search Constraints

Start Over You searched for: Author "Takeuchi, Ken" Remove constraint Author: "Takeuchi, Ken"
1,054 results on '"Takeuchi, Ken"'

Search Results

1. Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies

2. Involvement of Mediterranean fever gene mutations in colchicine-responsive enterocolitis: a retrospective cohort study

5. Anxiety and behavioral changes in Japanese patients with inflammatory bowel disease due to COVID-19 pandemic: a national survey

7. Final Analysis of COVID-19 Patients With Inflammatory Bowel Disease in Japan (J-COSMOS): A Multicenter Registry Cohort Study

9. Impact of twice‐daily budesonide foam administration on early clinical response and endoscopic remission in patients with ulcerative colitis: a post hoc analysis.

10. A review on the current status and definitions of activity indices in inflammatory bowel disease: how to use indices for precise evaluation

12. Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies

13. Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study

14. Efficacy and Safety of Etrasimod in Patients with Ulcerative Colitis in Japan: Data from the Phase 3 ELEVATE UC 12 and ELEVATE UC 40 JAPAN Trials.

15. Significance of Conducting 2 Types of Fecal Tests in Patients With Ulcerative Colitis

25. Development of the Novel e-Learning System, 'SPES NOVA' (Scalable Personality-Adapted Education System with Networking of Views and Activities)

29. Caspase inhibition in select olfactory neurons restores innate attraction behavior in aged Drosophila.

30. S4 Risankizumab Induction Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: Efficacy and Safety in the Randomized Phase 3 INSPIRE Study

33. Efficacy of Indigo Naturalis in a Multicenter Randomized Controlled Trial of Patients With Ulcerative Colitis

36. S1063 Improvement in Inflammatory Biomarker Levels Through Week 12 in Moderately to Severely Active Ulcerative Colitis Patients Treated With Guselkumab: Results From the Phase 3 QUASAR Induction Study

42. Final analysis of COVID-19 patients with inflammatory bowel disease in Japan (J-COSMOS): a multicenter registry cohort study

Catalog

Books, media, physical & digital resources